Skip to main content
Clinical Trials/PACTR202105734146484
PACTR202105734146484
Completed
Phase 1

Evaluation of the Safety and Tolerability of the ‘LeVe CPAP Flow Generator’ in Healthy Volunteers at Mengo Hospital in Kampala Uganda

Mengo Hospital0 sites20 target enrollmentMay 16, 2021
ConditionsRespiratory

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Respiratory
Sponsor
Mengo Hospital
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mengo Hospital

Eligibility Criteria

Inclusion Criteria

  • Staff members at Mengo Hospital
  • Age 20\-50 years

Exclusion Criteria

  • Current or ex\-smoker
  • Underlying respiratory conditions
  • Any contraindications from previous use of CPAP or oxygen therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Evaluation of the safety and tolerability of the primary posterior capsulotomy during femtosecond laser-assisted cataract surgeryH26.9H26.4Cataract, unspecifiedAfter-cataract
DRKS00010845niversitätsklinikum Knappschaftskrankenhaus Bochum GmbH Augenklinik41
Recruiting
N/A
The evaluation for safety and effectiveness of the laparoscopic radical hysterectomy and pelvic lymphadenectomy for stage IA, IB and IIA uterine cervical cancer.terine cervical cancer
JPRN-UMIN000016183agoya University Graduate School of Medicine, Department of Obstetrics and Gynecology10
Active, Not Recruiting
N/A
Safety and effectiveness clinical evaluation of the range of injectable medical devices HYDRAGEL C in facial aesthetic treatmentSubjects across groups present with moderate to severe facial aesthetic concerns, including peri-oral lines, nasolabial folds, lip volume deficits, and cheeks/cheekbones volume deficit, as gauged by various dermatological scalesSkin and Connective Tissue Diseases
ISRCTN13586698ouna Aesthetics75
Active, Not Recruiting
N/A
Clinical study to evaluate the safety and effectiveness of the use of two hyaluronic acid injectable products (Perfectha® Derm Lidocaine and Perfectha® Deep Lidocaine) in the treatment of lipsFor Perfectha® Derm Lidocaine: very thin to thin lip volume and with lip contour somewhat well-defined to poorly definedfor Perfectha® Deep Lidocaine: thin to moderate lip volumeNot Applicable
ISRCTN72858148Sinclair Pharma68
Completed
N/A
Evaluation of the safety and effectiveness of the MID-C/ApiFix system in adolescent idiopathic scoliosis.Spinal curvature1002837710005944
NL-OMON43676Vrije Universiteit Medisch Centrum33